These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole. Thone J J Neuropsychiatry Clin Neurosci; 2007; 19(4):481-2. PubMed ID: 18070865 [No Abstract] [Full Text] [Related]
5. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients. Chen CH; Huang MC; Lu ML J Clin Psychopharmacol; 2007 Oct; 27(5):516-7. PubMed ID: 17873689 [No Abstract] [Full Text] [Related]
6. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study. McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384 [TBL] [Abstract][Full Text] [Related]
7. Aripiprazole for the management of olanzapine-induced weight gain. Englisch S; Weinbrenner A; Inta D; Zink M Pharmacopsychiatry; 2009 Jul; 42(4):166-7. PubMed ID: 19585397 [No Abstract] [Full Text] [Related]
8. Diabetic ketoacidosis and elevated serum lipase in the setting of aripiprazole therapy. Kibbey KJ; Roberts AM; Nicholson GC Diabetes Care; 2010 Jul; 33(7):e96. PubMed ID: 20587716 [No Abstract] [Full Text] [Related]
9. Diabetic ketoacidosis associated with aripiprazole. Makhzoumi ZH; McLean LP; Lee JH; Ibe AI Pharmacotherapy; 2008 Sep; 28(9):1198-202. PubMed ID: 18752391 [TBL] [Abstract][Full Text] [Related]
10. Near fatal ketoacidosis with olanzapine treatment. Straker D; Mendelowitz A; Karlin L Psychosomatics; 2002; 43(4):339-40. PubMed ID: 12189265 [No Abstract] [Full Text] [Related]
11. Olanzapine-induced diabetic ketoacidosis in a Chinese man. Wong JO; Fu JC; Hung GB Hong Kong Med J; 2007 Feb; 13(1):73-4. PubMed ID: 17277396 [TBL] [Abstract][Full Text] [Related]
12. Diabetes and psychosis: olanzapine may not be the culprit. Levy P Hong Kong Med J; 2007 Aug; 13(4):335. PubMed ID: 17664543 [No Abstract] [Full Text] [Related]
14. Diabetic ketoacidosis associated with aripiprazole. Church CO; Stevens DL; Fugate SE Diabet Med; 2005 Oct; 22(10):1440-3. PubMed ID: 16176209 [TBL] [Abstract][Full Text] [Related]
15. Diabetic ketoacidosis associated with olanzapine in an adolescent patient. Selva KA; Scott SM J Pediatr; 2001 Jun; 138(6):936-8. PubMed ID: 11391346 [TBL] [Abstract][Full Text] [Related]
16. Diabetic ketoacidosis induced by aripiprazole in a 12-year-old boy. Dhamija R; Verma R Diabetes Care; 2008 Jun; 31(6):e50. PubMed ID: 18509137 [No Abstract] [Full Text] [Related]
17. Modulating effects of olanzapine on the development of diabetic ketoacidosis. Tsuchiyama N; Ando H; Ota T; Sakurai M; Takamura T Diabet Med; 2004 Mar; 21(3):300-1. PubMed ID: 15008848 [No Abstract] [Full Text] [Related]
19. Olanzapine abuse was relieved after switching to aripiprazole in a patient with psychotic depression. Lai CH Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1363-4. PubMed ID: 20691237 [No Abstract] [Full Text] [Related]
20. Extensive weight loss in a patient with schizophrenia after switching from olanzapine to aripiprazole. A case report. Luebbe G; Kropp S; Harms E; Ziegenbein M Pharmacopsychiatry; 2006 Mar; 39(2):76. PubMed ID: 16555168 [No Abstract] [Full Text] [Related] [Next] [New Search]